Application 208084
- Type
- ANDA
- Sponsor
- BAXTER HLTHCARE CORP
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | EQ 6MG BASE/ML | No | No |
| 002 | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | EQ 12MG BASE/ML | No | No |
| 003 | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | EQ 18MG BASE/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0338-3410 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3410 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3410 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3410 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3410 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3410 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3410 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3410 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3612 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3612 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3612 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3612 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3612 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3612 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3612 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3612 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3616 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3616 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3616 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3616 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3616 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3616 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3616 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3616 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3814 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3814 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3814 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3814 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3814 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3814 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3814 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-3814 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-4114 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-4114 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-4114 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-4114 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-4114 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-4114 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-4114 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 0338-4114 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 43066-993 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 43066-993 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 43066-995 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |
| 43066-995 | Clindamycin phosphate | Clindamycin phosphate | Baxter Healthcare Corporation | ANDA | Current |